ArticleJCO precision oncology2024

Clinical Utility of Molecular Tumor Board Review for Identification of Possible Germline Pathogenic Variants on Tumor Next-Generation Sequencing Reports.

Taylor A Rives et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.